Table 3: Fracture outcomes in residential care settings.

DurationRegimenCompliance (%)Total fracture patients (%)Non-vertebral fracture patients (%)Hip fracture patients (%)

Chapuy3 yearsCaD83NA255 (22)137 (12)
P84NA308 (27)178 (16)
RRRNA 28% ( )27% ( )
Decalyos II2 yearsCaD95NA17.8%27 (6.9)
PNA17.9%21 (11.1)
RRRNANSNS ( )
Flicker2 yearsCaD9525 (8)NANA
CaP35 (11)NANA
RRRNSNANA
Lips subgroupMax. 3.5 yearsD85NANA49 (6)
PNANA36 (5)
RRRNANANS
Meyer2 yearsD79%NA69 (12)50 (9)
PNA76 (13)47 (8)
RRRNANSNS
Lyons3 yearsD85205 (12)NA112 (6)
P218 (13)NA104 (6)
RRRNSNANS

ITT analysis unless otherwise stated. D: vitamin D; CaD: calcium and vitamin D combination treatment; P: placebo or control; NA: not available; NS: not significant; RRR: relative risk reduction.